Bleximenib
Bleximenib (JNJ-75276617) oxalate is an orally active and highly selective menin–KMT2A interaction inhibitor, with IC50 values of 0.1 nM in humans, 0.045 nM in mice, and ≤0.066 nM in dogs, Bleximenib effectively suppresses tumor cell proliferation while inducing apoptosis and cellular differentiation. Bleximenib serves as a powerful investigational agent for leukemia and other KMT2A-driven malignancies in preclinical cancer research.
Product Specifications
CAS Number
2654081-35-1
Smiles
[C@@H] (CCCN (CCOC) C) (C (C) C) N1CC2 (CN (CC2) C=3C (OC4=C (C (N (C (C) C) CC) =O) C=C (F) C=C4) =NN=CN3) C1
Molecular Formula
C32H50FN7O3
Molecular Weight
599.8
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2902829-01 20 µg
Recombinant Human Low affinity immunoglobulin gamma Fc region receptor III-A (FCGR3A)
Sign In for Pricing
View Details orb2902829-02 100 µg
Recombinant Human Low affinity immunoglobulin gamma Fc region receptor III-A (FCGR3A)
Sign In for Pricing
View Details 
039100-APC 200 µL
NPSR1, CT (NPSR1, GPR154, GPRA, PGR14, Neuropeptide S receptor, G-protein coupled receptor 154, G-protein coupled receptor PGR14, G-protein coupled receptor for asthma susceptibility) (APC) discontinued
Sign In for Pricing
View Details 